Ucb Biosciences Inc.: Cimzia (certolizumab Pegol), 2x200mg/ml Prefilled Syringes (2 Single-dose)
Cimzia Recall Summary UCB Biosciences is recalling specific batches of Cimzia (certolizumab pegol) prefilled syringes across the United States because the company cannot guarantee the product is sterile. This is a prescription medication used to treat inflammatory conditions. The recall affects three product types: standard prefilled syringes, professional samples, and starter kits distributed nationwide.
- Recalling firm
- UCB Biosciences Inc.
- Product
- cimzia (certolizumab pegol), 2x200mg/mL PREFILLED SYRINGES (2 single-dose), Rx ONLY, Manufactured by: UCB Inc., Smyrna, GA 30080, a) NDC 50474-710-79, b) Professional sample, NDC 50474-710-80; c) 3 cartons, STARTER KIT, NDC 50474-710-81.
- Reason
- Lack of Assurance of Sterility
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-05-08
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/1c27be06-091d-41e9-8325-1af2aed308d2